The stock price of Primoris Services (PRIM) slipped 3.1% after Guggenheim shifted its rating from Buy to Neutral, citing limited upcoming catalysts in the company’s power delivery business and ...

Alnylam Pharmaceuticals (ALNY) just secured a $500 million revolving credit facility, reflecting growing support from lenders as the company advances its pipeline of RNA interference therapies and ...